Ameritas Advisory Services’s Medifast MED Stock Holding History

Ameritas Advisory Services’s Portfolio MED Stock Details MED Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-10	Closed	-$141	–	2609
2025 Q2	$141	Buy	+10	New	+$131	﹤0.01%	2776
2023 Q2	–	Sell	-23	Closed	-$2.27K	–	1739
2023 Q1	$2.27K	Buy	+23	New	+$2.55K	﹤0.01%	2357

Other funds holding MED

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Lido Advisors Los Angeles, California $36.8B AUM 26.6% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Ameritas Advisory Services's MED Position: Q3 2025 in Review

Ameritas Advisory Services sold out of Medifast (MED) in Q3 2025, closing a stake of 10 shares — an estimated $141 sold.

Ameritas Advisory Services first reported a position in MED in Q1 2023 and held it in 2 quarters. The position peaked at $2.27K in Q1 2023. 123 funds tracked by Wall St. Rank hold MED as of Q3 2025.

Ameritas Advisory Services reported no remaining Medifast position as of Q3 2025 after selling out during the quarter.
Ameritas Advisory Services sold 10 Medifast shares in Q3 2025, an estimated $141.
Ameritas Advisory Services first reported a position in Medifast in Q1 2023 and held it in 2 quarters.
Ameritas Advisory Services's Medifast position peaked at $2.27K in Q1 2023.
123 funds tracked by Wall St. Rank held Medifast as of Q3 2025.

Based on Ameritas Advisory Services's 13F filing for Q3 2025, filed 6 Nov 2025.